Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 08-2025 | 08-2024 | 08-2023 | 08-2022 | 08-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,802 | 6,500 | 1,352 | 5,813 | 10,918 |
| Marketable Securities | 165 | 56 | 126 | 347 | 834 |
| Receivables | 368 | 154 | 175 | 202 | 342 |
| Inventories | N/A | N/A | 0 | 38 | 30 |
| TOTAL | $3,468 | $7,898 | $2,200 | $6,978 | $12,443 |
| Non-Current Assets | |||||
| PPE Net | 335 | 390 | 422 | 368 | 459 |
| Intangibles | 308 | 517 | 463 | 488 | 365 |
| Other Non-Current Assets | 64 | 64 | 0 | 0 | 0 |
| TOTAL | $707 | $970 | $884 | $856 | $824 |
| Total Assets | $4,175 | $8,868 | $3,084 | $7,834 | $13,267 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 8 |
| Accounts payable and accrued liabilities | 1,365 | 1,058 | 225 | 120 | 55 |
| TOTAL | $1,493 | $1,099 | $268 | $194 | $153 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 0 | 5 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 387 | 377 | 364 | 316 | 202 |
| TOTAL | $79 | $109 | $136 | $7 | $50 |
| Total Liabilities | $1,572 | $1,209 | $404 | $201 | $203 |
| Shareholders' Equity | |||||
| Common Shares | 20 | 16 | 8 | 6 | 6 |
| Retained earnings | -63,461 | -51,559 | -45,763 | -39,099 | -31,829 |
| Other shareholders' equity | -70 | -20 | 0 | 0 | 0 |
| TOTAL | $2,990 | $8,036 | $3,044 | $7,949 | $13,266 |
| Total Liabilities And Equity | $4,562 | $9,245 | $3,448 | $8,150 | $13,469 |